His scientific interests lie mostly in Internal medicine, Endocrinology, Angiotensin II, Inflammation and Proinflammatory cytokine. His study on Internal medicine is mostly dedicated to connecting different topics, such as Cell biology. His Endocrinology research integrates issues from Receptor, Cancer research, Cytokine and Monocyte.
He interconnects Renin–angiotensin system, Angiotensin-converting enzyme and Growth factor in the investigation of issues within Angiotensin II. His Inflammation study incorporates themes from Oxidative stress, Peripheral blood mononuclear cell and Pharmacology. His research in Proinflammatory cytokine intersects with topics in SOCS3, JAK-STAT signaling pathway and Janus kinase.
His primary areas of study are Internal medicine, Endocrinology, Immunology, Inflammation and Kidney. His Internal medicine research incorporates themes from Gastroenterology, Diabetes mellitus and Cardiology. The Tumor necrosis factor alpha research Jesús Egido does as part of his general Endocrinology study is frequently linked to other disciplines of science, such as Vascular smooth muscle, therefore creating a link between diverse domains of science.
His Immunology study combines topics in areas such as Nephropathy and Glomerulonephritis. His work deals with themes such as Oxidative stress, Cancer research, Cytokine and Pharmacology, which intersect with Inflammation. His Kidney research is multidisciplinary, incorporating perspectives in Acute kidney injury and Pathology.
Jesús Egido spends much of his time researching Internal medicine, Inflammation, Endocrinology, Kidney and Pharmacology. His studies in Internal medicine integrate themes in fields like Gastroenterology, Diabetes mellitus and Cardiology. The concepts of his Inflammation study are interwoven with issues in Acute kidney injury, Oxidative stress and Cancer research.
His work on Vitamin D and neurology is typically connected to Vascular smooth muscle as part of general Endocrinology study, connecting several disciplines of science. His study in Fibrosis extends to Kidney with its themes. As a part of the same scientific study, Jesús Egido usually deals with the Pharmacology, concentrating on Programmed cell death and frequently concerns with Heme oxygenase.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Inflammation and angiotensin II.
Yusuke Suzuki;Marta Ruiz-Ortega;Oscar Lorenzo;Monica Ruperez.
The International Journal of Biochemistry & Cell Biology (2003)
Angiotensin-Converting Enzyme Inhibition Prevents Arterial Nuclear Factor-κB Activation, Monocyte Chemoattractant Protein-1 Expression, and Macrophage Infiltration in a Rabbit Model of Early Accelerated Atherosclerosis
M. Hernández-Presa;C. Bustos;M. Ortego;J. Tuñon.
Circulation (1997)
HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis
Carmen Bustos;Miguel A Hernández-Presa;Mónica Ortego;José Tuñón.
Journal of the American College of Cardiology (1998)
Angiotensin II and Renal Fibrosis
Sergio A. Mezzano;Marta Ruiz-Ortega;Jesús Egido.
Hypertension (2001)
Transcription factor-κB (NF-κB) and renal disease
Carlos Guijarro;Jesús Egido.
Kidney International (2001)
TGF-β signaling in vascular fibrosis
Marta Ruiz-Ortega;Juan Rodríguez-Vita;Elsa Sanchez-Lopez;Gisselle Carvajal.
Cardiovascular Research (2007)
Glucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytes
R Largo;M.A Alvarez-Soria;I Dı́ez-Ortego;E Calvo.
Osteoarthritis and Cartilage (2003)
3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture
Carlos Guijarro;Luis Miguel Blanco-Colio;Mónica Ortego;Covadonga Alonso.
Circulation Research (1998)
Proinflammatory actions of angiotensins.
Marta Ruiz-Ortega;Oscar Lorenzo;Yusuke Suzuki;Mónica Rupérez.
Current Opinion in Nephrology and Hypertension (2001)
Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy
Sergio A. Mezzano;M. Alejandra Droguett;M. Eugenia Burgos;Leopoldo G. Ardiles.
Kidney International (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Autonomous University of Madrid
Instituto de Salud Carlos III
Inserm : Institut national de la santé et de la recherche médicale
Spanish National Centre for Cardiovascular Research
CEU San Pablo University
Karolinska Institute
Radboud University Nijmegen
MultiMedica
Biogen (United States)
University of Bari Aldo Moro
Inserm : Institut national de la santé et de la recherche médicale
Publications: 53
University of Chicago
Clemson University
Wuhan University of Technology
Ben-Gurion University of the Negev
Karolinska Institute
Oswaldo Cruz Foundation
University of East Anglia
National Institutes of Health
New York University
University of Lorraine
French Research Institute for Exploitation of the Sea
Cleveland Clinic
Harvard University
Stanford University
University of the Highlands and Islands
University of Connecticut